Literature DB >> 25881478

Wilms tumor 1 (WT1) protein: Diagnostic utility in pediatric tumors.

Lucia Salvatorelli1, Rosalba Parenti2, Giorgia Leone3, Giuseppe Musumeci4, Enrico Vasquez5, Gaetano Magro5.   

Abstract

Despite Wilms tumor 1 (WT1) protein was originally considered as a specific immunomarker of Wilms tumor, with the increasing use of immunohistochemistry, there is evidence that other tumors may share WT1 protein expression. This review focuses on the immunohistochemical profile of WT1 protein in the most common malignant tumors of children and adolescents. The variable expression and distribution patterns (nuclear vs cytoplasmic) in the different tumors, dependent on the antibodies used (anti-C or N-terminus WT1 protein), will be emphasized by providing explicative illustrations. Potential diagnostic pitfalls from unexpected WT1 protein expression in some tumors will be discussed in order to avoid diagnostic errors, especially when dealing with small biopsies.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Adolescents; Children; Review; Tumors; WT1

Mesh:

Substances:

Year:  2015        PMID: 25881478     DOI: 10.1016/j.acthis.2015.03.010

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  8 in total

1.  WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.

Authors:  Caroline Masserot; Qingyuan Liu; Eric Nguyen; Charles-Henry Gattolliat; Dominique Valteau-Couanet; Jean Bénard; Catherine Huber; Evelyne Ségal-Bendirdjian
Journal:  Mol Oncol       Date:  2015-10-21       Impact factor: 6.603

Review 2.  WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma.

Authors:  Daniela Maria Rasà; Agata Grazia D'Amico; Grazia Maugeri; Sebastiano Cavallaro; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2017-05-22       Impact factor: 3.444

Review 3.  Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.

Authors:  Joseph D Khoury; Wei-Lien Wang; Victor G Prieto; L Jeffrey Medeiros; Neda Kalhor; Meera Hameed; Russell Broaddus; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2017-08-24       Impact factor: 12.531

4.  Expression profile of Wilms Tumor 1 (WT1) isoforms in undifferentiated and all-trans retinoic acid differentiated neuroblastoma cells.

Authors:  Grazia Maugeri; Agata Grazia D'Amico; Daniela Maria Rasà; Rita Reitano; Salvatore Saccone; Concetta Federico; Rosalba Parenti; Gaetano Magro; Velia D'Agata
Journal:  Genes Cancer       Date:  2016-01

5.  Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms' Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49).

Authors:  Dorin Novacescu; Talida Georgiana Cut; Alin Adrian Cumpanas; Silviu Constantin Latcu; Razvan Bardan; Ovidiu Ferician; Cosmin-Ciprian Secasan; Andrei Rusmir; Marius Raica
Journal:  Biomedicines       Date:  2022-04-15

Review 6.  Immunohistochemical Markers of Soft Tissue Tumors: Pathologic Diagnosis, Genetic Contributions, and Therapeutic Options.

Authors:  David M Parham
Journal:  Anal Chem Insights       Date:  2015-10-29

7.  Desmoplastic Small Round Cell Tumor with "Pure" Spindle Cell Morphology and Novel EWS-WT1 Fusion Transcript: Expanding the Morphological and Molecular Spectrum of This Rare Entity.

Authors:  Gaetano Magro; Giuseppe Broggi; Angelica Zin; Vincenzo Di Benedetto; Mariaclaudia Meli; Andrea Di Cataldo; Rita Alaggio; Lucia Salvatorelli
Journal:  Diagnostics (Basel)       Date:  2021-03-18

8.  WT1 and Cyclin D1 Immunohistochemistry: A Useful Adjunct for Diagnosis of Pediatric Small Round Blue Cell Tumors on Small Biopsies.

Authors:  Lucia Salvatorelli; Rosalba Parenti; Giuseppe Broggi; Giada Maria Vecchio; Giuseppe Angelico; Lidia Puzzo; Andrea Di Cataldo; Vincenzo Di Benedetto; Rita Alaggio; Gaetano Magro
Journal:  Diagnostics (Basel)       Date:  2021-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.